Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation
Acute exacerbation (AE) is common for patients with chronic hepatitis B (CHB). The aim of the study is to investigate the values of hepatitis B core antibody (anti-HBc) IgM in CHB-AE. Patients were screened from a prospective sub-cohort, 419 CHB patients with AE were enrolled and divided into groups...
Saved in:
| Main Authors: | Ying Zhang, Ying Zhu, Yi Zhou, Zhaoxia Tan, Yunjie Dan, Xin Zou, Guohong Deng, Wenting Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Virulence |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21505594.2025.2534078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
by: Hae Lim Lee, et al.
Published: (2025-07-01) -
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
by: Bei Jiang, et al.
Published: (2025-12-01) -
Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01) -
Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment
by: Jian Wang, et al.
Published: (2025-08-01) -
HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)